In vitro activities of ampicillin, sulbactam and a combination of ampicillin and sulbactam against isolates of Acinetobacter calcoaceticus-Acinetobacter baumannii complex isolated in Chile between 1990 and 1998. - Suppr | 超能文献

In vitro activities of ampicillin, sulbactam and a combination of ampicillin and sulbactam against isolates of Acinetobacter calcoaceticus-Acinetobacter baumannii complex isolated in Chile between 1990 and 1998.

作者信息

Bello H, Domínguez M, González G, Zemelman R, Mella S, Young H K, Amyes S G

出版信息

J Antimicrob Chemother. 2000 May;45(5):712-3. doi: 10.1093/jac/45.5.712.

DOI:10.1093/jac/45.5.712

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

In vitro activities of ampicillin, sulbactam and a combination of ampicillin and sulbactam against isolates of Acinetobacter calcoaceticus-Acinetobacter baumannii complex isolated in Chile between 1990 and 1998.

J Antimicrob Chemother. 2000 May;45(5):712-3. doi: 10.1093/jac/45.5.712.

2

In-vitro activity of ampicillin/sulbactam against multiresistant Acinetobacter calcoaceticus var. anitratus clinical isolates.

J Antimicrob Chemother. 1994 Aug;34(2):298-300. doi: 10.1093/jac/34.2.298.

3

Susceptibility of the Acinetobacter calcoaceticus-A. baumannii complex to imipenem, meropenem, sulbactam and colistin.醋酸钙不动杆菌-鲍曼不动杆菌复合体对亚胺培南、美罗培南、舒巴坦和黏菌素的敏感性。

Int J Antimicrob Agents. 2004 May;23(5):487-93. doi: 10.1016/j.ijantimicag.2003.09.026.

4

In vitro investigation of the susceptibility of Acinetobacter baumannii strains isolated from clinical specimens to ampicillin/sulbactam alone and in combination with amikacin.

Int J Antimicrob Agents. 2002 Nov;20(5):390-2. doi: 10.1016/s0924-8579(02)00207-8.

5

Sulbactam treatment for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex.舒巴坦治疗涉及多重耐药醋酸钙不动杆菌-鲍曼不动杆菌复合体的肺炎。

Infect Dis (Lond). 2015 Jun;47(6):370-8. doi: 10.3109/00365548.2014.995129. Epub 2015 Mar 6.

6

Evaluation of the activities of two-drug combinations of rifampicin, polymyxin B and ampicillin/sulbactam against Acinetobacter baumannii.

J Antimicrob Chemother. 1998 Aug;42(2):270-1. doi: 10.1093/jac/42.2.270.

7

In vitro antibacterial activity of sulbactam-durlobactam in combination with other antimicrobial agents against Acinetobacter baumannii-calcoaceticus complex.舒巴坦-多利培南联合其他抗菌药物对鲍曼不动杆菌-醋酸钙不动杆菌复合体的体外抗菌活性。

Diagn Microbiol Infect Dis. 2024 Jul;109(3):116344. doi: 10.1016/j.diagmicrobio.2024.116344. Epub 2024 May 9.

8

In vitro effect of ampicillin/sulbactam on Acinetobacter species.

Microbios. 2001;106 Suppl 2:97-104.

9

In vitro activities of ampicillin-sulbactam and amoxicillin-clavulanic acid against Acinetobacter baumannii.氨苄西林-舒巴坦和阿莫西林-克拉维酸对鲍曼不动杆菌的体外活性。

J Clin Microbiol. 1998 Nov;36(11):3415-6. doi: 10.1128/JCM.36.11.3415-3416.1998.

10

Effect of sulbactam on infections caused by imipenem-resistant Acinetobacter calcoaceticus biotype anitratus.舒巴坦对耐亚胺培南醋酸钙不动杆菌鲍曼不动杆菌生物型所致感染的影响。

J Infect Dis. 1993 Feb;167(2):448-51. doi: 10.1093/infdis/167.2.448.

引用本文的文献

1

Antimicrobial Susceptibilities of Clinical Acinetobacter baumannii Isolates With Different Genotypes.不同基因型临床鲍曼不动杆菌分离株的抗菌药敏性

Jundishapur J Microbiol. 2014 Dec 7;7(12):e13347. doi: 10.5812/jjm.13347. eCollection 2014 Dec.

2

Efficacy and safety of Sultamicillin (Ampicillin/Sulbactan) and Amoxicillin/Clavulanic acid in the treatment of upper respiratory tract infections in adults--an open-label, multicentric, randomized trial.舒他西林（氨苄西林/舒巴坦）与阿莫西林/克拉维酸治疗成人上呼吸道感染的疗效及安全性——一项开放标签、多中心、随机试验

Braz J Otorhinolaryngol. 2006 Jan-Feb;72(1):104-11. doi: 10.1016/s1808-8694(15)30041-0.

3

Metallo-beta-lactamase-producing gram-negative bacilli: laboratory-based surveillance in cooperation with 13 clinical laboratories in the Kinki region of Japan.产金属β-内酰胺酶的革兰氏阴性杆菌：与日本近畿地区13家临床实验室合作开展的基于实验室的监测

J Clin Microbiol. 2004 Nov;42(11):5256-63. doi: 10.1128/JCM.42.11.5256-5263.2004.